SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 20.53 |
| Enterprise Value ($M) | -1.29 |
| Book Value ($M) | 14.48 |
| Book Value / Share | 0.36 |
| Price / Book | 1.42 |
| NCAV ($M) | 13.73 |
| NCAV / Share | 0.34 |
| Price / NCAV | 1.50 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.25 |
| Return on Assets (ROA) | -0.88 |
| Return on Equity (ROE) | -1.18 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.11 |
| Current Ratio | 2.11 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 26.83 |
| Assets | 27.58 |
| Liabilities | 13.10 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Hirschman Orin | 4.80 | -28.93 | |
| 13G | Pathstone Family Office, Llc | 7.53 | ||
| 13D/A | BIOS Memory SPV I, LP | 19.40 | 8.91 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 92,023 | 283,411 | 32.47 | |
| 71,923 | 232,270 | 30.97 | |
| 79,951 | 298,120 | 26.82 | |
| 295,406 | 791,115 | 37.34 | |
| 60,111 | 285,833 | 21.03 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BTMD – biote Corp. | CADL – Candel Therapeutics, Inc. |
| CARM – Carisma Therapeutics, Inc. | CHRS – Coherus BioSciences, Inc. |
| CLSD – Clearside Biomedical, Inc. |
Financial data and stock pages provided by
Fintel.io